 |
| Focus on Novel Nonopioid Analgesia References |
|
| Ackerman LL, Follett KA, Rosenquist RW. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage. 2003;26:668-677. Altman RD. Status of hyaluronan supplementation therapy in osteoarthritis. Curr Rheumatol Rep. 2003;5:7-14. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000;43:1905-1915. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-2984. Ashburn MA, Staats PS. Management of chronic pain. Lancet. 1999;353:1865-1869. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin J Pain. 2000;16(suppl 2):S12-S20. Bennett GJ. Neuropathic pain: new insights, new interventions. Hosp Pract (Off Ed). 1998;33:95-98, 101-104, 107-110. Bernard AM, Wright SW. Chronic pain in the ED. Am J Emerg Med. 2004;22:444-447. Bolay H, Moskowitz MA. Mechanisms of pain modulation in chronic syndromes. Neurology. 2002;59(5 suppl 2):S2-S7. Brookoff D. Chronic pain: 1. A new disease? Hosp Pract (Off Ed). 2000;35:45-52, 59. Chapman CR, Stillman M. Pathological pain. In: Kruger L, ed. Pain and Touch. Handbook of Perception and Cognition. 2nd ed. San Diego, Calif: Academic Press; 1996:315-342. Childers MK. How alpha-2 adrenergic agonists relieve pain. In: Childers MK, ed. Use of Alpha-2 Adrenergic Agonists in Pain Management. Columbia, Mo: Academic Information Systems; 2001:13-27. Coward DM. Tizanidine: neuropharmacology and mechanism of action. Neurology. 1994;44(11 suppl 9):S6-S11. Continuum Health Partners, Inc. Adjuvant medications. Available at: http://www.stoppain.org/pain_medicine/content/medication/adjuvants.asp. Accessed September 6, 2005. Criscuolo S, Auletta C, Lippi S, Brogi F, Brogi A. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. Acta Neurol Scand. 2005;111:229-232. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-1273. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9-19. emedicine Consumer Health. Medical acupuncture. Available at: http://www.emedicinehealth.com/fulltext/11678.htm. Accessed September 6, 2005. Fernando A, Chew G. Chronic insomnia secondary to chronic pain responding to quetiapine. Australas Psychiatry. 2005;13:86. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002;22:633-658. Fields HL. Depression and pain: a neurobiological model. Neuropsychiatry Neuropsychol Behav Neurol. 1991;4:83-92. Fishbain DA. Polypharmacy treatment approaches to the psychiatric and somatic comorbidities found in patients with chronic pain. Am J Phys Med Rehabil. 2005;84(suppl 3):S56-S63. Galer BS, Sheldon E, Patel N, Codding C, Burch F, Gammaitoni AR. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Curr Med Res Opin. 2004;20:1455-1458. Gallagher RM. Primary care and pain medicine. A community solution to the public health problem of chronic pain. Med Clin North Am. 1999;83:555-583. Gilliland BC. Fibromyalgia, arthritis associated with systemic disease, and other arthritides. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2004:2055-2064. Goadsby PJ. Current concepts of the pathophysiology of migraine. Neurol Clin. 1997;15:27-42. Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116:109-118. Gottschalk A, Smith DS. New concepts in acute pain therapy: preemptive analgesia. Am Fam Physician. 2001;63:1979-1984. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA. 1998;280:147-151. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(suppl 1):9-160. International Association for the Study of Pain. IASP pain terminology. Available at: http://www.iasp-pain.org/terms-p.html. Accessed June 23, 2005. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993;77:1048-1056. Internet permission granted by Lippincott Williams & Wilkins (http://www.lww.com). Krusz JC. Chronic headaches and a new approach to treatment using tizanidine. In: Childers MK, ed. Use of Alpha-2 Adrenergic Agonists in Pain Management. Columbia, Mo: Academic Information Systems; 2001:107-121. Larsen J. Current considerations in pain management for the patient with fibromyalgia syndrome. Pharm Times. 1999;66:2HPT-6HPT. Leventhal LJ. Management of fibromyalgia. Ann Intern Med. 1999;131:850-858. Magni G, Marchetti M, Moreschi C, Merskey H, Luchini SR. Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study. Pain. 1993;53:163-168. Maizels M, McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician. 2005;71:483-490. Manek NJ, Lane NE. Osteoarthritis: current concepts in diagnosis and management. Am Fam Physician. 2000;61:1795-1804. Manfredini D, Romagnoli M, Cantini E, Bosco M. Efficacy of tizanidine hydrochloride in the treatment of myofascial face pain. Minerva Med. 2004;95:165-171. Marcus DA. Treatment of nonmalignant chronic pain. Am Fam Physician. 2000;61:1331-1338, 1345-1346. Martin TJ, Eisenach JC. Pharmacology of opioid and nonopioid analgesics in chronic pain states. J Pharmacol Exp Ther. 2001;299:811-817. Mayo Clinic. Acupuncture relieves symptoms of fibromyalgia. Available at: http://www.newswise.com/articles/view/513812/. Accessed September 6, 2005. McNamara JO. Drugs effective in the therapy of the epilepsies. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:521-547. Medline Plus. Drug information: clonidine (parenteral-local). Available at: http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203089.html. Accessed September 6, 2005. Medline Plus. Drug information: clonidine (systemic). Available at: http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202152.html. Accessed September 6, 2005. Miaskowski C, Cleary J, Burney R, et al. Guideline for the Management of Cancer Pain in Adults and Children. APS Clinical Practice Guidelines Series, No. 3. Glenview, Ill: American Pain Society; 2005. National Institute of Neurological Disorders and Stroke. Pain: hope through research. Available at: http://www.ninds.nih.gov/disorders/chronic_pain/detail_chronic_pain.htm. Accessed June 30, 2005. NeurogesX. Study of NGX-4010 for treatment of painful HIV-associated neuropathy. Available at: http://clinicaltrials.gov/ct/show/NCT00085761. Accessed June 30, 2005. Neurontin® (gabapentin) prescribing information. New York, NY: Pfizer Inc; April 2005. Available at: http://www.pfizer.com/pfizer/download/uspi_neurontin.pdf. Accessed October 27, 2005. Nicholson B, Verma S. Comorbidities in chronic neuropathic pain. Pain Med. 2004;5(suppl 1):S9-S27. Nicholson BD. Diagnosis and management of neuropathic pain: a balanced approach to treatment. J Am Acad Nurse Pract. 2003;15(suppl 12):3-9. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage. 2000;19(suppl 1):S16-S20. Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain: attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001;50:145-151. Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain. 2005;6:253-260. Rico-Villademoros F, Hidalgo J, Dominguez I, Garcia-Leiva JM, Calandre EP. Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:161-164. RxList. Tizanidine. Available at: http://www.rxlist.com/cgi/generic/tizanidine_od.htm. Accessed November 3, 2005. Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004;109:26-35. Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache. 2002;42:470-482. Saper JR. Efficacy and tolerability of tizanidine as adjunctive therapy in the prophylaxis of chronic daily headache. In: Saper JR, ed. Alpha-2 Adrenergic Agonists: Evidence and Experience Examined. Lake Forest, Ill: Royal Society of Medicine Press, Ltd; 2002:13-22. Savage SR, Covington E, Heit H, Hunt J, Joranson DE, Schafer S. Definitions related to the use of opioids for the treatment of pain: a consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Available at: http://www.ampainsoc.org/advocacy/opioids2.htm. Accessed November 2, 2005. Semenchuk MR, Sherman S. Effectiveness of tizanidine in neuropathic pain: an open-label study. J Pain. 2000;1:285-292. Siddall PJ, Cousins MJ. Introduction to pain mechanisms: implications for neural blockade. In: Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. 3rd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1998:675-699. Silberstein SD, Lipton RB, Goadsby PJ. Chronic daily headache: diagnosis and treatment. In: Silberstein SD, Lipton RB, Goadsby PJ, eds. Headache in Clinical Practice. 2nd ed. London: Martin Dunitz, Ltd; 2002:129-147. Sinatra R. Role of COX-2 inhibitors in the evolution of acute pain management. J Pain Symptom Manage. 2002;24(suppl 1):S18-S27. Slagle MA. Pain management: medication update. South Med J. 2001;94:771-774. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443-2454. Todorov AA, Kolchev CB, Todorov AB. Tiagabine and gabapentin for the management of chronic pain. Clin J Pain. 2005;21:358-361. Topol EJ. Arthritis medicines and cardiovascular events—"house of coxibs." JAMA. 2005;293:366-368. Turk DC, Okifuji A. Pain terms and taxonomies of pain. In: Loeser D, Buter SH, Chapman CR, Turk DC, eds. Bonica's Management of Pain. Baltimore, Md: Lippincott Williams & Wilkins; 2001:17-25. Turk DC. Are pain syndromes acute or chronic diseases? Clin J Pain. 2000;16:279-280. Verbunt JA, Seelen HA, Vlaeyen JW, van der Heijden GJ, Knottnerus JA. Fear of injury and physical deconditioning in patients with chronic low back pain. Arch Phys Med Rehabil. 2003;84:1227-1232. Wagstaff AJ, Bryson HM. Tizanidine: a review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs. 1997;53:435-452. White WT, Patel N, Drass M, Nalamachu S. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med. 2003;4:321-330. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340:1888-1899. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959-1964. World Health Organization. WHO's pain ladder. Available at: http://www.who.int/cancer/palliative/painladder/en/index.html. Accessed September 6, 2005. Zanaflex® (tizanidine hydrochloride) prescribing information. Hawthorne, NY: Acorda® Therapeutics Inc; April 2005. Available at: http://www.zanaflexcapsules.com/Zanaflex_Insert.pdf. Accessed May 5, 2005. |
the Dannemiller Memorial Educational Foundation
and SynerMed® Communications.
from Acorda® Therapeutics
